4 White Blood Cell Disorders and Infection Risk
Review how white blood cell counts and neutropenia relate to infection risk, how leukemia can affect marrow function, and how nursing care prevents and responds to infection.
White blood cells and count abnormalities
White blood cells, also called leukocytes, are immune cells made mainly in the bone marrow. They include neutrophils, lymphocytes, monocytes, eosinophils, and basophils. A complete blood count (CBC) with differential reports the total white blood cell count and the proportions or numbers of these cell types; the is especially important when assessing infection risk.
An abnormal count is a finding, not a diagnosis. Interpret the CBC differential and trends alongside the patient's condition. Suspected blood cancers require additional clinical and laboratory evaluation.
and infection risk
is a low total white blood cell count. It can result from medicines, infection, immune disorders, or bone-marrow disease. is a low neutrophil count and may be caused by chemotherapy, other medicines, infection, immune conditions, or impaired marrow production.
Neutrophils are a key defense against many bacterial and fungal infections. The is calculated from the total white blood cell count and the proportion of neutrophils, including bands. is commonly described as mild at an of , moderate at , and severe below .
Infection risk generally rises as the falls, particularly when is severe or prolonged. The patient's history and the duration of also matter. With few neutrophils, infection can worsen quickly, and redness, pus, or other typical inflammatory signs may be subtle or absent.
is an elevated white blood cell count. Infection and inflammation are possible causes, but a high count alone does not establish the cause. Lymphopenia, lymphocytosis, eosinophilia, and monocytosis describe low or high levels of their corresponding cell types; their significance depends on the count, symptoms, history, and other test results.
and marrow function
is a group of cancers that begin in blood-forming tissues. Abnormal cells accumulate in the marrow and may enter the blood. They can crowd out normal blood-cell production, so a patient may have anemia, low platelets, and too few effective infection-fighting cells—even when the total white blood cell count is high.
Leukemias are classified by the affected cell lineage, either lymphoid or myeloid, and by how quickly the disease typically progresses, either acute or chronic. Common types are acute lymphoblastic (ALL), acute myeloid (AML), chronic lymphocytic (CLL), and chronic myeloid (CML).
Acute leukemias can progress rapidly. Symptoms may include fatigue, fever or recurrent infection, easy bruising or bleeding, and bone pain. Chronic leukemias may be found on a routine blood test or cause enlarged lymph nodes, fullness from an enlarged spleen, fatigue, or recurrent infections. These symptoms are not specific to ; diagnosis depends on appropriate testing and specialist assessment.
Preventing infection and monitoring
Trend the CBC with differential and , noting the patient's treatment cycle, prior counts, symptoms, and other signs of marrow suppression. Use the patient's care plan and local protocols to guide precautions.
Use standard precautions and reliable hand hygiene. Clean hands before and after patient contact and before and after catheter or wound care. Encourage the patient, visitors, and staff to clean their hands, and limit close contact with people who are ill.
Assess for early or subtle infection. Check temperature and vital signs as indicated, and assess the mouth, skin, wounds, urine, respiratory status, and vascular access sites. Do not rely on a normal-looking site or a high white blood cell count to exclude infection.
Reduce avoidable exposure and trauma by following prescribed line-care and oral-care practices. Avoid rectal temperatures, suppositories, and rectal procedures when contraindicated by the care plan or protocol, because tissue injury can create an entry point for infection.
Teach patients whom to contact and how to obtain urgent help after hours. Do not recommend special isolation, restrictive diets, or preventive medicines unless indicated by the treating team's risk assessment and protocol.
Responding to fever or suspected infection
For a patient with or receiving cancer treatment, a temperature of () or higher should prompt immediate contact with the oncology team or urgent medical evaluation, according to the patient's instructions. Do not wait to see whether the temperature rises or take a fever-reducing medicine before seeking guidance. Fever during chemotherapy can be a medical emergency. Other signs of infection or sudden deterioration also require prompt assessment, even without fever.
Priorities for suspected infection or fever include:
Assess airway, breathing, circulation, mental status, temperature, and other vital signs; activate emergency or sepsis pathways for instability.
Notify the responsible clinician promptly and communicate the , treatment history, symptoms, and time of onset.
Obtain ordered blood cultures and other indicated specimens promptly, following facility protocol; include vascular access cultures when ordered. Do not let specimen collection delay emergency treatment.
Support rapid evaluation for . Empiric antibacterial treatment is time-critical; ASCO/IDSA guidance endorses giving the initial dose within hour of triage. Follow local protocols and prescribed orders.
Reassess and document the patient's response, specimen collection, notifications, and treatment times. Escalate new or worsening symptoms without delay.